Effect of Debaryomyces hansenii combined with Qiweibaizhu powder extract on the gut microbiota of antibiotic-treated mice with diarrhea.

3 Biotech
Guozhen XieZhoujin Tan

Abstract

The aim of this study was to investigate the effects of an extract of Qiweibaizhu powder combined with Debaryomyces hansenii on the gut microbiota of antibiotic-treated mice with diarrhea. Mice were gavaged with a mixture of gentamycin sulfate and cefradine to induce diarrhea. After diarrhea was observed, 25% dose of ultra-micro Qiweibaizhu powder extract combined with 25% dose of Debaryomyces hansenii (QCD) was gavaged to mice with diarrhea. DNA of intestinal contents in mice was extracted for 16S rRNA gene sequence analysis by high-throughput sequencing following treatment finished. The results showed that the QCD increased the species richness and diversity, but did not recover the diversity to the original level. Antibiotics and QCD significantly altered the composition of gut microbiota at different taxonomic levels. At the genus level, the relative abundance of Bacteroidales S24-7 group_unidentified and Bacteroides returned to baseline after QCD treatment. Additionally, QCD suppressed the growth of Oscillospira and Ruminococcus, and promoted the proliferation of Erysipelotrichaceae_norank and Blautia compared with the healthy and diarrheal mice. Our results indicated that QCD modulated the diversity and composition of the...Continue Reading

References

Nov 3, 1998·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·C HögenauerE C Reisinger
Apr 11, 2009·PLoS Computational Biology·James Robert WhiteMihai Pop
Apr 13, 2010·Nature Methods·J Gregory CaporasoRob Knight
Aug 11, 2010·Current Opinion in Infectious Diseases·Elizabeth C Wick, Cynthia L Sears
Aug 17, 2010·Bioinformatics·Robert C Edgar
Jun 22, 2011·Genome Research·Daniel H HusonStephan C Schuster
Dec 26, 2012·Frontiers in Microbiology·Rima HatoumIsmail Fliss
May 15, 2013·Proceedings of the National Academy of Sciences of the United States of America·Amandine EverardPatrice D Cani
Jul 10, 2013·Environmental Microbiology·Natalya Yutin, Michael Y Galperin
Dec 24, 2015·The Cochrane Database of Systematic Reviews·Joshua Z GoldenbergBradley C Johnston
Jan 13, 2016·Journal of Pediatric Gastroenterology and Nutrition·Hania SzajewskaUNKNOWN ESPGHAN Working Group for ProbioticsPrebiotics
Feb 3, 2016·Cell Reports·Joshua S LichtmanJoshua E Elias
Feb 16, 2016·Microbial Pathogenesis·Muriel DerrienWillem M de Vos
Jul 20, 2016·World Journal of Microbiology & Biotechnology·Honeylet Sabas OchangcoNils Arneborg
Dec 28, 2016·Journal of Agricultural and Food Chemistry·Wei-Wei DongLin-Hu Quan
Feb 7, 2017·Gastroenterology Clinics of North America·Michael A SilvermanJeffrey S Gerber
Jul 18, 2017·Frontiers in Microbiology·Sayaka Fujio-VejarMartin Gotteland
Dec 25, 2017·Microbial Pathogenesis·Mohamed ZeineldinJames Lowe
Jun 2, 2018·BioMed Research International·Md Abul Kalam AzadJie Yin
Jan 19, 2019·Applied Microbiology and Biotechnology·Miriam AnguloCarlos Angulo
Jan 31, 2019·Frontiers in Microbiology·Marta HernándezJose María Eiros

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.